Private Advisor Group, LLC Cellectar Biosciences, Inc. Transaction History

Private Advisor Group, LLC

  • $15.6 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 02, 2020
SELL
$10.6 - $16.6 $5,300 - $8,300
-500 Closed
0 $0
Q2 2020

Aug 17, 2020
BUY
$10.3 - $17.3 $5,150 - $8,650
500 New
500 $1,000
Q4 2019

Feb 10, 2020
SELL
$10.6 - $24.1 $142,040 - $322,940
-13,400 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$18.6 - $28.2 $249,240 - $377,880
13,400 New
13,400 $0

About Cellectar Biosciences, Inc.

CLRB Quotes by TradingView
  • Ticker CLRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 6,114,290
  • Market Cap $13M
  • Description
  • Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's ma...
More about CLRB
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email